Founder Partner Launch

Renominate is entering its structured expansion phase.

To ensure every early-stage partner receives direct founder-led oversight and measured implementation, we are limiting intake during launch.

We are looking to work with a small number of pharmacies in this initial phase so that:

• Each Founder Partner receives direct senior involvement
• Implementation remains controlled and structured
• Reporting standards are refined using real-world data
• Long-term programme quality is protected

This approach ensures success for every partner — not rapid scale at the expense of standards.

Ground-Floor Positioning

Founder Partners participate at the foundational stage of the Renominate programme.

As the framework matures and real-world data strengthens reporting benchmarks, the programme will be rolled out commercially under standard rate structures.

Founder Partners secure:

• Protected £10 per re-nominated patient (lifetime, while email programme remains active)
• Preferential pricing across all Renominate services
• 20% preferential structure across current DHM Digital services
• Priority access to future programme developments
• Founder-level strategic involvement

This founding-stage commercial protection will not be replicated once the programme moves to full commercial rollout.

Flexible Participation

Founder Partner status reflects full programme alignment.

However, pharmacies who are not yet ready for full implementation may engage with individual services independently.

These services remain available at standard commercial rates and can be introduced progressively.

Founder status is designed for pharmacies seeking comprehensive, structured retention support — but participation is never framed as all-or-nothing.

Why Founder Intake Is Limited

Limiting intake during launch allows:

• Direct founder-led service
• Personalised implementation
• Controlled engagement volumes
• Measured commercial benchmarking
• Refinement of long-term reporting standards

Once the launch cohort is complete and operational data is established, Renominate will expand under standard programme pricing.

Next Step

If your pharmacy would like to secure Founder Partner positioning during this launch phase:

Apply for Founder Partner Status HERE